Session Information

  • WCLC 2021

    2021 World Conference on Lung Cancer

    Conference Program for 2021 the World Conference on Lung Cancer

    Presentation Date(s):  
    • September 8 - 14, 2021
    • Total Presentations: 1107

    All times listed are in Mountain Time MDT (UTC-6:00)

    PL - Plenary
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    FP - Featured Posters
    P - Posters
    WS - Workshops
    IS - Industry Symposium
    MTE - Meet the Expert
    BEDG - Brain Exchange Discussion Groups

Filter Results:

Show Only CME Accredited Sessions

  • +

    P24 - Liquid Biopsy and Other Non-invasive Diagnostic Modalities - Targeted Therapy

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Liquid Biopsy and Other Non-invasive Diagnostic Modalities
    • +

      P24.03 - Dynamic Circulating Tumor DNA Interim Results From The ALKternate Clinical Trial

      00:00 - 00:00  |  Presenter: Malinda Itchins

      • Abstract

      Loading...

  • +

    P52 - Novel Therapeutics and Targeted Therapies - KRAS

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Novel Therapeutics and Targeted Therapies
    • +

      P52.03 - Efficacy of Sotorasib in KRAS p.G12C-Mutated NSCLC with Stable Brain Metastases: A Post-Hoc Analysis of CodeBreaK 100

      00:00 - 00:00  |  Presenter: Suresh Ramalingam

      • Abstract

      Loading...

  • +

    ES04 - Antibody–Drug Conjugates: Current Status and Future Perspectives*

    • 09:00 - 09:35
    • 9/10/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Education Session
    • Track: Novel Therapeutics and Targeted Therapies
    *Full-length Educational talk will be available as pre-release content as of September 1. The Live Day Educational Sessions will feature brief summaries and extended live discussion with the presenters. Delegates are encouraged to watch the pre-released content prior to watching the live Educational Sessions.
    • +

      ES04.01 - Structure and Mechanism of Antibody Drug Conjugates

      09:00 - 09:02  |  Presenter: Bob T. Li

      • Abstract

      No abstract available for this presentation

  • +

    MA14 - Pathologic Patterns, Genomic Alterations and Targeted Therapies in NSCLC

    • 18:45 - 19:45
    • 9/13/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Mini Oral
    • Track: Predictive Tumor Based Assays/ Biomarkers/ Pathology
    • +

      MA14.03 - Genomic Profiles and Potential Determinants of Response and Resistance in KRAS p.G12C-mutated NSCLC Treated With Sotorasib

      18:55 - 19:00  |  Presenter: Ferdinandos Skoulidis

      • Abstract

      Loading...